Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians

Medical Hypotheses

Volumn 72, Issue 6, 2009, Pages 647-651

  McCarty, Mark F ^a  

^a Natural Alternatives International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE; VITAMIN D;

ACUTE PHASE RESPONSE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE EXACERBATION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MORTALITY; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; SKIN PIGMENTATION; SUN EXPOSURE; UPREGULATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

EID: 62949191749     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.12.031     Document Type: Article

References (102)

1. Yajnik C.S., Lubree H.G., Rege S.S., Naik S.S., Deshpande J.A., Deshpande S.S., et al. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab 87 (2002) 5575-5580
2. Ramachandran A., Snehalatha C., and Vijay V. Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Res Clin Pract 65 (2004) 189-195
3. Misra A., and Vikram N.K. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 20 (2004) 482-491
4. Raji A., Seely E.W., Arky R.A., and Simonson D.C. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 86 (2001) 5366-5371
5. Ruderman N., Chisholm D., Pi-Sunyer X., and Schneider S. The metabolically obese, normalweight individual revisited. Diabetes 47 (1998) 699-713
6. Chandalia M., Abate N., Garg A., Stray-Gundersen J., and Grundy S.M. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84 (1999) 2329-2335
7. Sevak L., McKeigue P.M., and Marmot M.G. Relationship of hyperinsulinemia to dietary intake in south Asian and European men. Am J Clin Nutr 59 (1994) 1069-1074
8. Abate N., Chandalia M., Snell P.G., and Grundy S.M. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab 89 (2004) 2750-2755
9. Clark F., Simpson W., and Young J.R. Osteomalacia in immigrants from the Indian subcontinent in Newcastle upon Tyne. Proc R Soc Med 65 (1972) 478-480
10. Hodgkin P., Hine P.M., Kay G.H., Lumb G.A., and Stanbury S.W. Vitamin-D deficiency in Asians at home and in Britain. Lancet 2 (1973) 167-171
11. Harinarayan C.V., Gupta N., and Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf) 43 (1995) 351-358
12. Goswami R., Gupta N., Goswami D., Marwaha R.K., Tandon N., and Kochupillai N. Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr 72 (2000) 472-475
13. Arya V., Bhambri R., Godbole M.M., and Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int 15 (2004) 56-61
14. Harinarayan C.V., Ramalakshmi T., and Venkataprasad U. High prevalence of low dietary calcium and low vitamin D status in healthy south Indians. Asia Pac J Clin Nutr 13 (2004) 359-364
15. Alekel D.L., Mortillaro E., Hussain E.A., West B., Ahmed N., Peterson C.T., et al. Lifestyle and biologic contributors to proximal femur bone mineral density and hip axis length in two distinct ethnic groups of premenopausal women. Osteoporos Int 9 (1999) 327-338
16. Awumey E.M., Mitra D.A., Hollis B.W., Kumar R., and Bell N.H. Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study. J Clin Endocrinol Metab 83 (1998) 169-173
17. Lo C.W., Paris P.W., and Holick M.F. Indian and Pakistani immigrants have the same capacity as Caucasians to produce vitamin D in response to ultraviolet irradiation. Am J Clin Nutr 44 (1986) 683-685
18. Prager R., Schernthaner G., Niederle B., and Roka R. Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery. Calcif Tissue Int 46 (1990) 1-4
19. Kautzky-Willer A., Pacini G., Niederle B., Schernthaner G., and Prager R. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (Oxf) 37 (1992) 147-155
20. Kumar S., Olukoga A.O., Gordon C., Mawer E.B., France M., Hosker J.P., et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol (Oxf) 40 (1994) 47-53
21. Richards M.L., and Thompson N.W. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy?. Surgery JID-0417347 126 (1999) 1160-1166
22. Kautzky-Willer A., Pacini G., Barnas U., Ludvik B., Streli C., Graf H., et al. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int JID-0323470 47 (1995) 200-206
23. Grey A.B., Evans M.C., Stapleton J.P., and Reid I.R. Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism. Ann Intern Med JID-0372351 121 (1994) 745-749
24. Grey A., and Reid I. Body weight and bone mineral density in hyperparathyroidism. Ann Intern Med JID-0372351 123 (1995) 732 Grey, A
25. Stein M.S., Flicker L., Scherer S.C., Paton L.M., O'Brien M.L., Walton S.C., et al. Relationships with serum parathyroid hormone in old institutionalized subjects. Clin Endocrinol (Oxf) JID-0346653 54 (2001) 583-592
26. Hulter H.N., Melby J.C., Peterson J.C., and Cooke C.R. Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens JID-8510461 2 (1986) 360-370
27. Lind L., Wengle B., Wide L., Sorensen O.H., and Ljunghall S. Hypertension in primary hyperparathyroidism-reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study. Am J Hypertens JID-8803676 1 (1988) 397-402
28. Lind L., Wengle B., Lithell H., and Ljunghall S. Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long-term treatment with active vitamin D (alphacalcidol). J Intern Med JID-8904841 231 (1992) 427-432
29. Sancho J.J., Rouco J., Riera-Vidal R., and Sitges-Serra A. Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World J Surg JID-7704052 16 (1992) 732-735
30. Raine A.E., Bedford L., Simpson A.W., Ashley C.C., Brown R., Woodhead J.S., et al. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int JID-0323470 43 (1993) 700-705
31. Symons C., Fortune F., Greenbaum R.A., and Dandona P. Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism-an association. Br Heart J 54 (1985) 539-542
32. London G.M., de Vernejoul M.C., Fabiani F., Marchais S.J., Guerin A.P., Metivier F., et al. Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32 (1987) 900-907
33. Park C.W., Oh Y.S., Shin Y.S., Kim C.M., Kim Y.S., Kim S.Y., et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33 (1999) 73-81
34. Grey A., Mitnick M.A., Shapses S., Ellison A., Gundberg C., and Insogna K. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption-a clinical research center study. J Clin Endocrinol Metab 81 (1996) 3450-3454
35. Passeri G., Pini G., Troiano L., Vescovini R., Sansoni P., Passeri M., et al. Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab 88 (2003) 5109-5115
36. Nilsson I.L., Aberg J., Rastad J., and Lind L. Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 128 (2000) 895-902
37. Ramirez G., Brueggemeyer C.D., and Newton J.L. Cardiac arrhythmias on hemodialysis in chronic renal failure patients. Nephron 36 (1984) 212-218
38. Andersson P., Rydberg E., and Willenheimer R. Primary hyperparathyroidism and heart disease-a review. Eur Heart J 25 (2004) 1776-1787
39. Palmer M., Adami H.O., Bergstrom R., Akerstrom G., and Ljunghall S. Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 102 (1987) 1-7
40. Hedback G., Tisell L.E., Bengtsson B.A., Hedman I., and Oden A. Premature death in patients operated on for primary hyperparathyroidism. World J Surg 14 (1990) 829-835
41. Hedback G., and Oden A. Increased risk of death from primary hyperparathyroidism-an update. Eur J Clin Invest 28 (1998) 271-276
42. Iida-Klein A., Guo J., Takemura M., Drake M.T., Potts Jr. J.T., Abou-Samra A., et al. Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTHrelated protein receptor result in selective loss of PTH-stimulated phospholipase C activity. J Biol Chem 272 (1997) 6882-6889
43. Ni Z., Smogorzewski M., and Massry S.G. Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology 135 (1994) 1837-1844
44. Begum N., Sussman K.E., and Draznin B. Calcium-induced inhibition of phosphoserine phosphatase in insulin target cells is mediated by the phosphorylation and activation of inhibitor 1. J Biol Chem 267 (1992) 5959-5963
45. Schluter K.D., Weber M., and Piper H.M. Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem J 310 Pt 2 (1995) 439-444
46. McCarty M.F. A moderately low phosphate intake may provide health benefits analogous to those conferred by UV light - a further advantage of vegan diets. Med Hypotheses 61 (2003) 543-560
47. McCarty M.F., and Thomas C.A. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 61 (2003) 535-542
48. McCarty M.F. Vitamin D, Parathyroid hormone, and insulin sensitivity. Am J Clin Nutr 80 (2004) 1451-1452
49. McCarty M.F. Nutritional modulation of parathyroid hormone secretion may influence risk for left ventricular hypertrophy. Med Hypotheses 64 (2005) 1015-1021
50. McCarty M.F. Secondary hyperparathyroidism promotes the acute phase response - a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses 64 (2005) 1022-1026
51. McCarty M.F. Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias? Med. Hypotheses 72 (2009) 581-583
52. Sambrook P.N., Chen J.S., March L.M., Cameron I.D., Cumming R.G., Lord S.R., et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 89 (2004) 5477-5481
53. Kamycheva E., Sundsfjord J., and Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur J Cardiovasc Prev Rehabil 11 (2004) 69-74
54. Chiu K.C., Chuang L.M., Lee N.P., Ryu J.M., McGullam J.L., Tsai G.P., et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism JID-0375267 49 (2000) 1501-1505
55. Baynes K.C., Boucher B.J., Feskens E.J., and Kromhout D. Vitamin D, Glucose tolerance and insulinaemia in elderly men. Diabetologia JID-0006777 40 (1997) 344-347
56. Chiu K.C., Chu A., Go V.L., and Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79 (2004) 820-825
57. Parikh S.J., Edelman M., Uwaifo G.I., Freedman R.J., Semega-Janneh M., Reynolds J., et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol.Metab 89 (2004) 1196-1199
58. Kamycheva E., Sundsfjord J., and Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol 151 (2004) 167-172
59. Brickman A., Nyby M., von Hungen K., Eggena P., and Tuck M. Parathyroid hormone, platelet calcium, and blood pressure in normotensive subjects. Hypertension 18 (1991) 176-182
60. Morfis L., Smerdely P., and Howes L.G. Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures. J Hypertens 15 (1997) 1271-1276
61. Saleh F.N., Schirmer H., Sundsfjord J., and Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24 (2003) 2054-2060
62. Scragg R., Holdaway I., Singh V., Metcalf P., Baker J., and Dryson E. Serum 25- hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract JID-8508335 27 (1995) 181-188
63. Scragg R., Sowers M., and Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27 (2004) 2813-2818
64. Cosman F., Morgan D.C., Nieves J.W., Shen V., Luckey M.M., Dempster D.W., et al. Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res 12 (1997) 958-966
65. Scragg R., Jackson R., Holdaway I.M., Lim T., and Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 19 (1990) 559-563
66. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., and Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000) 690-693
67. Arunabh S., Pollack S., Yeh J., and Aloia J.F. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88 (2003) 157-161
68. Looker A.C. Body fat and vitamin D status in black versus white women. J Clin Endocrinol. Metab (2004)
69. Vieth R., Chan P.C., and MacFarlane G.D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr JID-0376027 73 (2001) 288-294
70. Krause R., Buhring M., Hopfenmuller W., Holick M.F., and Sharma A.M. Ultraviolet B and blood pressure. Lancet JID-2985213R 352 (1998) 709-710
71. Pfeifer M., Begerow B., Minne H.W., Nachtigall D., and Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86 (2001) 1633-1637
72. Sanchez M., de la Sierra A., Coca A., Poch E., Giner V., and Urbano-Marquez A. Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension JID-7906255 29 (1997) 531-536
73. Colditz G.A., Manson J.E., Stampfer M.J., Rosner B., Willett W.C., and Speizer F.E. Diet and risk of clinical diabetes in women. Am J Clin Nutr 55 (1992) 1018-1023
74. Weinberger M.H., Wagner U.L., and Fineberg N.S. The blood pressure effects of calcium supplementation in humans of known sodium responsiveness. Am J Hypertens 6 (1993) 799-805
75. MacGregor G.A., and Cappuccio F.P. The kidney and essential hypertension: a link to osteoporosis?. J Hypertens 11 (1993) 781-785
76. Zemel M.B., Shi H., Greer B., Dirienzo D., and Zemel P.C. Regulation of adiposity by dietary calcium. FASEB J 14 (2000) 1132-1138
77. Heaney R.P., Davies K.M., and Barger-Lux M.J. Calcium and weight: clinical studies. J Am Coll.Nutr 21 (2002) 152S-155S
78. Heaney R.P. Normalizing calcium intake: projected population effects for body weight. J Nutr 133 (2003) 268S-270S
79. Zemel M.B., and Miller S.L. Dietary calcium and dairy modulation of adiposity and obesity risk. Nutr Rev 62 (2004) 125-131
80. Zemel M.B., Thompson W., Milstead A., Morris K., and Campbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 12 (2004) 582-590
81. Van den B.G., Van Roosbroeck D., Vanhove P., Wouters P.J., De Pourcq L., and Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 88 (2003) 4623-4632
82. Arai H., Miyamoto K., Taketani Y., Yamamoto H., Iemori Y., Morita K., et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res JID-8610640 12 (1997) 915-921
83. Colin E.M., Weel A.E., Uitterlinden A.G., Buurman C.J., Birkenhager J.C., Pols H.A., et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol (Oxf) 52 (2000) 211-216
84. Whitfield G.K., Remus L.S., Jurutka P.W., Zitzer H., Oza A.K., Dang H.T., et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177 (2001) 145-159
85. Zofkova I., Zajickova K., and Hill M. Serum parathyroid hormone levels are associated with FokI polymorphism of the vitamin D receptor gene in untreated postmenopausal women. Eur J Intern Med 14 (2003) 232-236
86. Chiu KC, Chuang LM, Yoon C. The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet EDAT- 2001/03/07 10:00 MHDA- 2001/03/07 10:00 PHST- 2001/Jan/06 [received] PHST- 2001/Feb/15 [accepted] PHST- 2001/Feb/15 [aheadofprint] PST -ppublish 1902;2:2.
87. Roth S.M., Zmuda J.M., Cauley J.A., Shea P.R., and Ferrell R.E. Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci 59 (2004) 10-15
88. Gross C., Eccleshall T.R., Malloy P.J., Villa M.L., Marcus R., and Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11 (1996) 1850-1855
89. Chen H.Y., Chen W.C., Hsu C.D., Tsai F.J., and Tsai C.H. Relation of vitamin D receptor FokI start codon polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal women in Taiwan. Acta Obstet Gynecol Scand 81 (2002) 93-98
90. Zajickova K., Zofkova I., Bahbouh R., and Krepelova A. Vitamin D receptor gene polymorphisms, bone mineral density and bone turnover: FokI genotype is related to postmenopausal bone mass. Physiol Res 51 (2002) 501-509
91. Vidal C., Grima C., Brincat M., Megally N., and Xuereb-Anastasi A. Associations of polymorphisms in the vitamin D receptor gene (BsmI and FokI) with bone mineral density in postmenopausal women in Malta. Osteoporos Int 14 (2003) 923-928
92. Gennari L., Becherini L., Mansani R., Masi L., Falchetti A., Morelli A., et al. FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. J Bone Miner Res 14 (1999) 1379-1386
93. Lucotte G., Mercier G., and Burckel A. The vitamin D receptor FokI start codon polymorphism and bone mineral density in osteoporotic postmenopausal French women. Clin Genet 56 (1999) 221-224
94. Kanan R.M., Varanasi S.S., Francis R.M., Parker L., and Datta H.K. Vitamin D receptor gene start codon polymorphism (FokI) and bone mineral density in healthy male subjects. Clin Endocrinol (Oxf) 53 (2000) 93-98
95. Choi Y.M., Jun J.K., Choe J., Hwang D., Park S.H., Ku S.Y., et al. Association of the vitamin D receptor start codon polymorphism (FokI) with bone mineral density in postmenopausal Korean women. J Hum Genet 45 (2000) 280-283
96. Keatinge W.R., and Donaldson G.C. Cardiovascular mortality in winter. Arctic Med Res JID-8602204 54 Suppl 2 (1995) 16-18
97. van Rossum C.T., Shipley M.J., Hemingway H., Grobbee D.E., Mackenbach J.P., and Marmot M.G. Seasonal variation in cause-specific mortality: are there high-risk groups? 25-year follow-up of civil servants from the first Whitehall study. Int J Epidemiol JID-7802871 30 (2001) 1109-1116
98. Peter I., Otremski I., and Livshits G. Geographic variation in vascular mortality in Eurasia: spatial autocorrelation analysis of mortality variables and risk factors. Ann Hum Biol 23 (1996) 471-490
99. Scragg R., Khaw K.T., and Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 49 (1995) 640-646
100. Reasner C.A., Dunn J.F., Fetchick D.A., Liel Y., Hollis B.W., Epstein S., et al. Alteration of vitamin D metabolism in Mexican-Americans. J Bone Miner Res 5 (1990) 13-17
101. Abrams S.A., Copeland K.C., Gunn S.K., Stuff J.E., Clarke L.L., and Ellis K.J. Calcium absorption and kinetics are similar in 7- and 8-year-old Mexican-American and Caucasian girls despite hormonal differences. J Nutr 129 (1999) 666-671
102. Thompson P.L., Bradshaw P.J., Veroni M., and Wilkes E.T. Cardiovascular risk among urban Aboriginal people. Med J Aust 179 (2003) 143-146